PDI - Resultado de Búsqueda

Luis Marcelo Villanueva Olivares

Oncólogo medico , UNIVERSIDAD DE CHILE. Chile, 2004
medico, UNIVERSIDAD DE CHILE. Chile, 1995
MSc Cancer therapeutics , UNIVERSITY OF LONDON. Chile, 2012
Magister administracion salud, UNIVERSIDAD DE CHILE. Chile, 2024

medico Part Time

UNIVERSIDAD DE CHILE

medicina

santiago, Chile

2009 - At present


Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort Rha S.Y.; Castanon, E; Gill S.; Senellart, H; Lopez J.; Marquez-Rodas, I; Victoria, I; Kim, TM; Lwin, Z; Burger, MC; et al. Article ISI SCOPUS Cancer (2025)
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study Graff, JN; Burotto M.; Fong, PC; Pook, DW; Zurawski B.; Kopp R.M.; Salinas J.; Bylow, KA; Kramer, G; Ratta, R; et al. Article ISI SCOPUS Annals of Oncology (2025)
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302) Lara, PN Jr; Villanueva L.; Ibanez C.; Erman M.; Lee J.L.; Heinrich, D; Lipatov O.N.; Gedye, C; Gokmen E.; Acevedo A.; et al. Article ISI SCOPUS BMC Cancer (2024)
Recommendations about the Programming of Medical Activities in Medical Oncology of the Chilean Society of Medical Oncology Bertin, Rodrigo; Madrid, Jorge; Villanueva, Luis; Berrios, Marcela Article ISI SCIELO SCOPUS (2023)
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Powles T.; Tomczak P.; Park S.H.; Venugopal B.; Ferguson T.; Symeonides S.N.; Hajek J.; Gurney H.; Chang Y.H.; Lee J.L.; et al. Article SCOPUS The Lancet Oncology (2022)
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial Fuchs, Charles; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Villanueva, Luis; Goekkurt, Eray; et al. Article ISI SCOPUS JAMA Oncology (2020)
Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: Impact on pathological complete response and safety Villanueva L.; Anabalon J.; Butte J.M.; Salman P.; Panay S.; Milla E.; Gallardo C.; Hoefler S.; Charles R.; Reyes F.; et al. Article ISI SCOPUS ecancermedicalscience (2020)
Analysis of prognostic factors for gallbladder cancer (GBC) of patients assisted in an academic hospital in Chile Villanueva, Luis; Uribe, Rodrigo; Aguilera, Oscar; Munoz, Renato Article ISI JOURNAL OF CLINICAL ONCOLOGY (2018)
Complete preoperative chemotherapy regimen FLOT: Evaluating the safety and histopathologic results in gastric cancer (GC). Villanueva, Luis; Gallardo, Carlos; Reyes, Felipe; Charles, Roberto; Enrique Panay, Sergio; Alejandra Munoz, Maria Article ISI JOURNAL OF CLINICAL ONCOLOGY (2018)
Palliative treatment for locally advanced or metastatic gallbladder cancer: conclusions of the Latin American Consensus meeting for the management of gallbladder cancer Muller B.; Arroyo G.; Gallardo J.; Villanueva L.; Gonzalez P.; Baeza R.; De Aretxabala X.; Maluenda F.; Acevedo A.; Chuecas, F; et al. Article ISI REVISTA MEDICA DE CHILE (2011)
Quimiorradioterapia adyuvante en el cáncer gástrico resecado con intención curativa: Análisis de supervivencia y toxicidad de pacientes tratados entre 1995 y 2003 en el Instituto Nacional del Cáncer, Chile Müller, Bettina; Balbontín, Paulina; Carcamo, Marcela; Trujillo, Cristian; Becerra, Sergio; Solá, Antonio; Neveu, Rodrigo; Fernandez, Roberto; Buchholtz, Martín; Villanueva, Luis; et al. Article SCIELO REVISTA MEDICA DE CHILE (2009)
Results of adjuvant chemoradiation after curative surgery for gastric cancer. A retrospective study Muller B.; Balbontin, P; Carcamo M.; Trujillo C.; Becerra S.; Sola A.; Neveu, R; FernÃ¡ndez R.; Buchholtz M.; Villanueva L.; et al. Article ISI REVISTA MEDICA DE CHILE (2009)


Pembrolizumab plus FLOT vs FLOT as neoadjuvant and adjuvant therapy in locally advanced gastric and gastroesophageal junction cancer: Interim analysis of the phase 3 KEYNOTE-585 study. Al-Batran S.E.; Shitara K.; Folprecht G.; Moehler M.H.; Goekkurt E.; Ben-Aharon I.; Lonardi S.; Stein S.; Hubert A.; Chau I.; et al. Abstract ISI SCOPUS Journal of Clinical Oncology (2024)
DETERMINATION OF THE HER2 EXPRESSION IN CHILEAN PATIENTS WITH GASTRIC CANCER Painemal C.; Berrios M.; Gallegos I.; Martin C.S.; Villanueva L.; Barajas O.; Ahumada M.; Fuentes, R. Abstract ISI ANNALS OF ONCOLOGY (2012)
Therapy for advanced gallbladder cancer: Improving survival Gallardo J.; Rubio B.; Ahumada M.; Barajas O.; Villanueva L.; Diaz J.; De Aretxabala X.; Reyes J. Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2008)
Chemotherapy in metastatic gallbladder cancer: Improving the results Gallardo J.; Rubio B.; Villanueva L.; Barajas O.; Ahumada M. Abstract ISI CANCER INVESTIGATION (2007)
Treatment of unresectable or metastatic gallbladder cancer with single-agent gemcitabine or in combination with cisplatin. Gallardo J.; Rubio B.; Barajas O.; Villanueva L.; Fodor M. Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2005)


Manejo paliativo del cáncer de vesícula biliar irresecable o metastásico: Conclusiones del Consenso Latinoamericano de Manejo del Cáncer de Vesícula Biliar Müller, Bettina; ARROYO, GERARDO; Gallardo, Jorge; Villanueva, Luis; Gonzalez, Pablo; Baeza, Ramón; De Aretxabala, Xabier; Maluenda, Fernando; Acevedo, Alejandro; CHUECAS, FERNANDO; et al. Comentario SCIELO SCOPUS REVISTA MEDICA DE CHILE (2011)


Gallbladder cancer, a different disease that needs individual trials Gallardo J.; Rubio B.; Villanueva L.; Barajas O. Letter ISI SCOPUS JOURNAL OF CLINICAL ONCOLOGY (2005)

4

Monica Ahumada

medico

medicina oncologia basico clinica

HOSPITAL CLINICO UNIVERSIDAD DE CHILE

santiago, Chile

1

Marcelo Garrido

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1

IVAN GALLEGOS

PATHOLOGIST, LABORATORY DIRECTOR

PATHOLOGY

HOSPITAL CLINICO DE UNIVERSIDAD DE CHILE

SANTIAGO, Chile

2

Marcela Cárcamo

Profesor

Epidemiología y Estudios en Salud

Universidad de Los Andes

Santiago, Chile

2

Bettina Müller

Jefe subrogante

Oncología Médica

Instituto Nacional del Cáncer

Santiago, Chile

4

Betzabe Rubio

study coordinator farmacovigilancia

Instituto de Terapias Oncologicas Providencia

santiago, Chile

2

Berta Cerda

Director

Instituto Nacional del Cáncer

Santiago, Chile

4

Olga Barajas

PROF. ASOCIADA/MEDICO ONCOLOGO

MEDICINA

HOSPITAL CLINICO UNIVERSIDAD DE CHILE

Santiago, Chile

1

Sergio Portiño

1

Carlos Gallardo

JEFE TECNICO

INVESTIGACION DEL CANCER

CLINICA ONCOLOGIA FUNDACION ARTURO LOPEZ PEREZ

SANTIAGO, Chile

2

Pamela Salman

Full Professor

Facultad de Medicina y Ciencias de la Salud

Universidad Mayor de Chile

Santiago, Chile

2

Roberto Charles

Cirujano Digestivo

Cirugía

Fundación Arturo López Pérez

Santiago, Chile

19

Luis Villanueva

1

SEBASTIAN HOEFLER

Jefe de Equipo

Cirugia

Instituto Oncologico FALP

Santiago, Chile